Assorted news from last week: The FDA has granted a rare pediatric disease designation (RPDD) to lutetium-177(177Lu)-omburtamab-DTPA for use as a potential therapeutic option in
[vc_row][vc_column][vc_column_text] Assorted news from last week: CAC2 Member Mary Beth Collins, highlights the importance of Childhood Cancer License Plates, how they amplify awareness efforts, the
Assorted news from the last two weeks: In recognition of Childhood Cancer Awareness Month, NCI Director Ned Sharpless reflected on the progress that’s been made
Assorted news from the last week: This video abstract breaks down financial toxicity issues for families with special health care needs. Researchers have discovered that
Assorted news from the last week: The White House issued a proclamation for Childhood Cancer Awareness Month on September 1. Canadian gold illumination! For every
Assorted news from the last week: Research led by SickKids and the Montreal Children’s Hospital of the McGill University Health Centre found that a novel
Assorted news from the last week: Study finds cancer screening tool may help predict risk of developing new cancer among childhood cancer survivors. NCI has
Assorted news from the last week: The STAR Act was crafted by parents, doctors, and organizations who strive to make a difference for children with
This collaborative research effort was due in part to childhood cancer groups coming together as part of CAC2. CAC2 salutes CAC2 Member Organizations The Andrew
Assorted news from the last week: New York Times op-ed piece by CNN investigative reporter Andrew Kaczynski on the financial toxicity of a childhood cancer
